{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:48:21Z","timestamp":1776235701797,"version":"3.50.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.brainres.2025.150002","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:00:35Z","timestamp":1761058835000},"page":"150002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The traffic jam hypothesis: Unravelling cellular dysfunctions in Parkinsonism diseases"],"prefix":"10.1016","volume":"1868","author":[{"given":"Megha","family":"Manne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brijesh","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-0896","authenticated-orcid":false,"given":"Milind","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-0682","authenticated-orcid":false,"given":"Madhura","family":"Vinchurney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2025.150002_b0005","article-title":"Biology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorder","author":"Alexander","year":"2022","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.brainres.2025.150002_b0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","article-title":"Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor,\u201cprefrontal\u201d and \u201climbic\u201d functions","volume":"85","author":"Alexander","year":"1991","journal-title":"Prog. Brain Res."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0015","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/s41467-024-46554-8","article-title":"Neuropathogenesis-on-chips for neurodegenerative diseases","volume":"15","author":"Amartumur","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.brainres.2025.150002_b0020","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.nbd.2015.06.008","article-title":"Ambroxol-induced rescue of defective glucocerebrosidase is associated with increased LIMP-2 and saposin C levels in GBA1 mutant Parkinson's disease cells","volume":"82","author":"Ambrosi","year":"2015","journal-title":"Neurobiol. Dis."},{"issue":"22","key":"10.1016\/j.brainres.2025.150002_b0025","doi-asserted-by":"crossref","first-page":"12379","DOI":"10.3390\/ijms252212379","article-title":"Parkinson\u2019s disease: biomarkers for diagnosis and disease progression","volume":"25","author":"Arya","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1468-1331.2009.02900.x","article-title":"Neurotransmission in Parkinson\u2019s disease: beyond dopamine","volume":"17","author":"Barone","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0045","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.brainres.2025.150002_b0050","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","article-title":"Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis","volume":"76","author":"Bridel","year":"2019","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.brainres.2025.150002_b0055","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s007020100005","article-title":"Functional imaging studies on dopamine and motor control","volume":"108","author":"Brooks","year":"2001","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.brainres.2025.150002_b0065","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0070","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-023-05672-9","article-title":"Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction","volume":"14","author":"Calabresi","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1097-4547(19990401)56:1<28::AID-JNR4>3.0.CO;2-2","article-title":"Influence of MPP+ on the state of tubulin polymerisation in NGF\u2010differentiated PC12 cells","volume":"56","author":"Cappelletti","year":"1999","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0085","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1471-4159.2010.06924.x","article-title":"Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+\u2010induced neurodegeneration","volume":"115","author":"Cartelli","year":"2010","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.brainres.2025.150002_b0090","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tcb.2006.08.002","article-title":"Microtubule motors at the intersection of trafficking and transport","volume":"16","author":"Caviston","year":"2006","journal-title":"Trends Cell Biol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3727\/000000006783981990","article-title":"Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis","volume":"15","author":"Carvey","year":"2006","journal-title":"Cell Transplant."},{"issue":"4","key":"10.1016\/j.brainres.2025.150002_b0105","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1002\/mco2.315","article-title":"Applications of multi\u2010omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.brainres.2025.150002_b0110","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV \u03b1-synucleinopathy","volume":"29","author":"Chung","year":"2009","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2025.150002_b0115","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.brainres.2025.150002_b0120","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41531-024-00799-8","article-title":"Human midbrain organoids: a powerful tool for advanced Parkinson\u2019s disease modeling and therapy exploration","volume":"10","author":"Cui","year":"2024","journal-title":"npj Parkinson's Dis."},{"issue":"19","key":"10.1016\/j.brainres.2025.150002_b0130","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1305623110","article-title":"TFEB-mediated autophagy rescues midbrain dopamine neurons from \u03b1-synuclein toxicity","volume":"110","author":"Decressac","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"37","key":"10.1016\/j.brainres.2025.150002_b0135","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1523\/JNEUROSCI.1920-10.2010","article-title":"Pathogenic lysosomal depletion in Parkinson's disease","volume":"30","author":"Dehay","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2025.150002_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2015.09.048","article-title":"Biomarkers in Parkinson's disease: advances and strategies","volume":"22","author":"Delenclos","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.neuro.31.061307.090711","article-title":"Role of axonal transport in neurodegenerative diseases","volume":"31","author":"De Vos","year":"2008","journal-title":"Annu. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2025.150002_b0150","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinsons Dis."},{"issue":"12","key":"10.1016\/j.brainres.2025.150002_b0155","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0165","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12974-015-0375-8","article-title":"The disruption of mitochondrial axonal transport is an early event in neuroinflammation","volume":"12","author":"Errea","year":"2015","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0170","article-title":"Cognition deficits in Parkinson\u2019s disease: mechanisms and treatment","volume":"2020","author":"Fang","year":"2020","journal-title":"Parkinson\u2019s Disease"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0175","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/s41598-017-04232-4","article-title":"Synuclein impairs trafficking and signaling of BDNF in a mouse model of Parkinson\u2019s disease","volume":"7","author":"Fang","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108263","article-title":"Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses","volume":"33","author":"Fernandes","year":"2020","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109333","article-title":"Altered conformation of \u03b1-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson\u2019s disease","volume":"36","author":"Fonseca-Ornelas","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.brainres.2025.150002_b0200","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12035-013-8489-4","article-title":"Integrating pathways of Parkinson's disease in a molecular interaction map","volume":"49","author":"Fujita","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.brainres.2025.150002_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fnana.2015.00005","article-title":"Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state","volume":"9","author":"Galvan","year":"2015","journal-title":"Front. Neuroanat."},{"issue":"6248","key":"10.1016\/j.brainres.2025.150002_b0210","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255555","article-title":"Alzheimer\u2019s and Parkinson\u2019s diseases: the prion concept in relation to assembled A\u03b2, tau, and \u03b1-synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0215","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/21541248.2016.1199191","article-title":"Traffic jams and the complex role of \u03b1-Synuclein aggregation in Parkinson disease","volume":"8","author":"Gon\u00e7alves","year":"2017","journal-title":"Small GTPases"},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.150002_b0220","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2009.08.021","article-title":"Brainstem pathology and non-motor symptoms in PD","volume":"289","author":"Grinberg","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0230","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1152\/physrev.00023.2007","article-title":"Intracellular transport and kinesin superfamily proteins, KIFs: structure, function, and dynamics","volume":"88","author":"Hirokawa","year":"2008","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0235","article-title":"Modeling Parkinson\u2019s disease using induced pluripotent stem cells","volume":"2020","author":"Hu","year":"2020","journal-title":"Stem Cells Int."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0240","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.tins.2014.12.009","article-title":"Impaired intracellular trafficking defines early Parkinson's disease","volume":"38","author":"Hunn","year":"2015","journal-title":"Trends Neurosci."},{"issue":"9","key":"10.1016\/j.brainres.2025.150002_b0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5483\/BMBRep.2019.52.9.186","article-title":"LRRK2 and membrane trafficking: nexus of Parkinson\u2019s disease","volume":"52","author":"Hur","year":"2019","journal-title":"BMB Rep."},{"issue":"42","key":"10.1016\/j.brainres.2025.150002_b0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7465","key":"10.1016\/j.brainres.2025.150002_b0255","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2025.150002_b0260","doi-asserted-by":"crossref","first-page":"7212","DOI":"10.1523\/JNEUROSCI.0711-11.2011","article-title":"The Parkinsonian mimetic, MPP+, specifically impairs mitochondrial transport in dopamine axons","volume":"31","author":"Kim-Han","year":"2011","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2025.150002_b0265","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.stem.2023.05.015","article-title":"Advanced human iPSC-based preclinical model for Parkinson\u2019s disease with optogenetic alpha-synuclein aggregation","volume":"30","author":"Kim","year":"2023","journal-title":"Cell Stem Cell"},{"issue":"6676","key":"10.1016\/j.brainres.2025.150002_b0270","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.brainres.2025.150002_b0275","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.3390\/ijms21197113","article-title":"Patient-derived induced pluripotent stem cell-based models in Parkinson\u2019s disease for drug identification","volume":"21","author":"Kouroupi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40035-024-00430-z","article-title":"Blood\u2013brain barrier alterations and their impact on Parkinson\u2019s disease pathogenesis and therapy","volume":"13","author":"Lau","year":"2024","journal-title":"Trans. Neurodegen."},{"key":"10.1016\/j.brainres.2025.150002_b0285","first-page":"1","article-title":"Microglia-driven inflammation induces progressive tauopathies and synucleinopathies","author":"Lee","year":"2025","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0290","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/cne.22040","article-title":"Subventricular zone neural progenitors from rapid brain autopsies of elderly subjects with and without neurodegenerative disease","volume":"515","author":"Leonard","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.brainres.2025.150002_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113087","article-title":"NR1H4 ameliorates Parkinson\u2019s disease via inhibiting astrocyte activation and neuroinflammation in a CEBP\u03b2\/NF-\u03baB dependent manner","volume":"142","author":"Li","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.brainres.2025.150002_b0305","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2478\/s13380-012-0044-7","article-title":"Pathologies of axonal transport in neurodegenerative diseases","volume":"3","author":"Liu","year":"2012","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.brainres.2025.150002_b0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the Global Burden of Disease Study 2021","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.brainres.2025.150002_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102849","article-title":"Effects of GLP-1 receptor agonists on mitochondrial function, inflammatory markers and leukocyte-endothelium interactions in type 2 diabetes","volume":"66","author":"Luna-Marco","year":"2023","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0325","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","article-title":"Axonal transport: cargo-specific mechanisms of motility and regulation","volume":"84","author":"Maday","year":"2014","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0330","article-title":"Pathophysiology of motor dysfunction in Parkinson\u2019s disease as the rationale for drug treatment and rehabilitation","volume":"2016","author":"Magrinelli","year":"2016","journal-title":"Parkinson\u2019s Disease"},{"key":"10.1016\/j.brainres.2025.150002_b0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.neurobiolaging.2018.12.001","article-title":"Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI","volume":"76","author":"Massa","year":"2019","journal-title":"Neurobiol. Aging"},{"issue":"7","key":"10.1016\/j.brainres.2025.150002_b0345","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.1520335113","article-title":"\u03b1-Synuclein\u2013induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models","volume":"113","author":"Mazzulli","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150002_b0350","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/sj.mp.4000446","article-title":"Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease","volume":"3","author":"Mezey","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2025.150002_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104623","article-title":"Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation","volume":"134","author":"Mezias","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.150002_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.593822","article-title":"Non-dopaminergic systems in Parkinson\u2019s disease","volume":"11","author":"Miguelez","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0365","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn3380","article-title":"Axonal transport deficits and neurodegenerative diseases","volume":"14","author":"Millecamps","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.brainres.2025.150002_b0370","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal dysfunction and \u03b1\u2010Synuclein aggregation in Parkinson's disease: diagnostic links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0375","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-017-0154-3","article-title":"Therapeutic potential of autophagy-enhancing agents in Parkinson\u2019s disease","volume":"12","author":"Moors","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1\u20132","key":"10.1016\/j.brainres.2025.150002_b0385","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0006-8993(01)02866-9","article-title":"GDNF is a major component of trophic activity in DA-depleted striatum for survival and neurite extension of DAergic neurons","volume":"916","author":"Nakajima","year":"2001","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0390","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1083\/jcb.140.3.659","article-title":"Visualization of the dynamics of synaptic vesicle and plasma membrane proteins in living axons","volume":"140","author":"Nakata","year":"1998","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.brainres.2025.150002_b0395","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.envint.2017.04.010","article-title":"Occupational pesticide use and Parkinson's disease in the Parkinson Environment Gene (PEG) study","volume":"107","author":"Narayan","year":"2017","journal-title":"Environ. Int."},{"key":"10.1016\/j.brainres.2025.150002_b0400","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of \u03b1-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.25373","article-title":"Parkinson's disease and alpha synuclein: is Parkinson's disease a prion\u2010like disorder?","volume":"28","author":"Olanow","year":"2013","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0410","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41531-025-01004-0","article-title":"Imaging advances to detect non-motor prodromal markers of Parkinson\u2019s disease and explore therapeutic translation opportunities","volume":"11","author":"Palanivel","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"14","key":"10.1016\/j.brainres.2025.150002_b0415","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.119.044948","article-title":"Association of Parkinson disease with risk of cardiovascular disease and all-cause mortality: a nationwide, population-based cohort study","volume":"141","author":"Park","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3233\/JPD-2011-11046","article-title":"Disentangling the relationship between lewy bodies and nigral neuronal loss in Parkinson's disease","volume":"1","author":"Parkkinen","year":"2011","journal-title":"Journal of Parkinson\u2019s Disease"},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0425","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/antiox13020240","article-title":"Mitochondria dysfunction and neuroinflammation in neurodegeneration: who comes first?","volume":"13","author":"Peggion","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.brainres.2025.150002_b0430","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","article-title":"Back to the tubule: microtubule dynamics in Parkinson\u2019s disease","volume":"74","author":"Pellegrini","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"issue":"30","key":"10.1016\/j.brainres.2025.150002_b0440","doi-asserted-by":"crossref","first-page":"7813","DOI":"10.1073\/pnas.1713129115","article-title":"\u03b1-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies","volume":"115","author":"Prots","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2025.150002_b0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13041-017-0340-9","article-title":"Oxidative stress and cellular pathologies in Parkinson\u2019s disease","volume":"10","author":"Puspita","year":"2017","journal-title":"Mol. Brain"},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0450","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/mds.870020201","article-title":"Young onset Parkinson's disease","volume":"2","author":"Quinn","year":"1987","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"6","key":"10.1016\/j.brainres.2025.150002_b0460","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.3390\/pharmaceutics14061252","article-title":"CRISPR-Cas9-based technology and its relevance to gene editing in Parkinson\u2019s disease","volume":"14","author":"Rahman","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.brainres.2025.150002_b0465","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00702-022-02509-1","article-title":"Life style and Parkinson\u2019s disease","volume":"129","author":"Reichmann","year":"2022","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2025.150002_b0480","doi-asserted-by":"crossref","first-page":"8083","DOI":"10.1523\/JNEUROSCI.1091-10.2010","article-title":"A pathologic cascade leading to synaptic dysfunction in \u03b1-synuclein-induced neurodegeneration","volume":"30","author":"Scott","year":"2010","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.brainres.2025.150002_b0490","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","article-title":"Biomarkers in Parkinson\u2019s disease (recent update)","volume":"63","author":"Sharma","year":"2013","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.brainres.2025.150002_b0495","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003620","article-title":"Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis","volume":"3","author":"Shen","year":"2013","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.brainres.2025.150002_b0500","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.cell.2011.02.010","article-title":"PARIS (ZNF746) repression of PGC-1\u03b1 contributes to neurodegeneration in Parkinson's disease","volume":"144","author":"Shin","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2025.150002_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.ircmb.2017.07.001","article-title":"Membrane trafficking in autophagy","volume":"336","author":"Soreng","year":"2018","journal-title":"Int. Rev. Cell Mol. Biol."},{"issue":"6645","key":"10.1016\/j.brainres.2025.150002_b0510","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0515","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009399","article-title":"\u03b1-Synuclein in Parkinson's disease","volume":"2","author":"Stefanis","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"31","key":"10.1016\/j.brainres.2025.150002_b0520","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.1103295108","article-title":"Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo","volume":"108","author":"Sterky","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2025.150002_b0525","article-title":"Blood-brain barrier: from physiology to disease and back","author":"Sweeney","year":"2018","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.brainres.2025.150002_b0530","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41582-020-0344-4","article-title":"Parkinson disease and the immune system\u2014associations, mechanisms and therapeutics","volume":"16","author":"Tan","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2025.150002_b0535","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson\u2019s: a syndrome rather than a disease?","volume":"124","author":"Titova","year":"2017","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2025.150002_b0545","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/ars.2010.3779","article-title":"The interplay between mitochondrial dynamics and mitophagy","volume":"14","author":"Twig","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"5674","key":"10.1016\/j.brainres.2025.150002_b0550","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","article-title":"Hereditary early-onset Parkinson's disease caused by mutations in PINK1","volume":"304","author":"Valente","year":"2004","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.brainres.2025.150002_b0555","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","article-title":"\u03b1-Synuclein-based animal models of Parkinson's disease: challenges and opportunities in a new era","volume":"39","author":"Visanji","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2025.150002_b0560","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nbd.2016.12.008","article-title":"Effects of \u03b1-synuclein on axonal transport","volume":"105","author":"Volpicelli-Daley","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.brainres.2025.150002_b0565","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.585584","article-title":"Molecular mechanisms of glutamate toxicity in Parkinson\u2019s disease","volume":"14","author":"Wang","year":"2020","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.brainres.2025.150002_b0570","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson's disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.brainres.2025.150002_b0575","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/mds.27823","article-title":"Neuronal vulnerability in Parkinson disease: should the focus be on axons and synaptic terminals?","volume":"34","author":"Wong","year":"2019","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.brainres.2025.150002_b0580","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00702-023-02635-4","article-title":"The heterogeneity of Parkinson\u2019s disease","volume":"130","author":"W\u00fcllner","year":"2023","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.brainres.2025.150002_b0585","article-title":"Reduced cortical cholinergic innervation measured using [18F]-FEOBV PET imaging correlates with cognitive decline in mild cognitive impairment","volume":"34","author":"Xia","year":"2022","journal-title":"NeuroImage: Clinical"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0590","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12974-024-03043-5","article-title":"Parkinson\u2019s disease-derived \u03b1-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype","volume":"21","author":"Yildirim-Balatan","year":"2024","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.brainres.2025.150002_b0600","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1038\/s41467-019-13413-w","article-title":"LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson\u2019s disease patients","volume":"10","author":"Ysselstein","year":"2019","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.brainres.2025.150002_b0605","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1242\/dmm.028738","article-title":"The role of Ca2+ signaling in Parkinson's disease","volume":"10","author":"Zaichick","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"52","key":"10.1016\/j.brainres.2025.150002_b0615","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001059","article-title":"Pgc-1 \u03b1, a potential therapeutic target for early intervention in parkinson\u2019s disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.brainres.2025.150002_b0620","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.neurobiolaging.2010.11.010","article-title":"Striatal dopamine transporter binding correlates with serum BDNF levels in patients with striatal dopaminergic neurodegeneration","volume":"33","author":"Ziebell","year":"2012","journal-title":"Neurobiol. Aging"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325005657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899325005657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T15:03:23Z","timestamp":1761923003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899325005657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":103,"alternative-id":["S0006899325005657"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150002","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The traffic jam hypothesis: Unravelling cellular dysfunctions in Parkinsonism diseases","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2025.150002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150002"}}